Luc W.M. Eurlings

Learn More
AIMS Natriuretic peptide-guided (NP-guided) treatment of heart failure has been tested against standard clinically guided care in multiple studies, but findings have been limited by study size. We sought to perform an individual patient data meta-analysis to evaluate the effect of NP-guided treatment of heart failure on all-cause mortality. METHODS AND(More)
BACKGROUND Cardiac troponin T measured by a high-sensitivity assay (hs-cTnT) recently proved to be of prognostic value in several populations. The hs-cTnT assay may also improve risk stratification in acute dyspnea. METHODS We prospectively studied the prognostic value of hs-cTnT in 678 consecutive patients presenting to the emergency department with(More)
  • A.-P P, S.-V W, +21 authors Papageorgiou
  • 2015
I schemic heart disease is the leading cause of death in Europe and the US 1 and represents a huge socioeconomic burden. With improved treatment strategies, patient mortality is decreasing, yet acute post–infarct-related heart failure (HF) because of infarct expansion remains a major problem, 2 lacking targeted molecular therapy. Therefore, better(More)
  • 1